Effect of drug formulation on the treatment of epilepsy
The paper describes a trial dealing with the effect of the formulation of an antiepileptic drug on therapy efficiency, safety, and compliance in epileptic patients. Switching from sustained-release valproates to Depakine®Chronosphere™ demonstrates how the values of efficiency, safety, and compliance...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2013-12-01
|
| Series: | Неврология, нейропсихиатрия, психосоматика |
| Subjects: | |
| Online Access: | https://nnp.ima-press.net/nnp/article/view/214 |
| _version_ | 1797876472481841152 |
|---|---|
| author | S. G. Burd |
| author_facet | S. G. Burd |
| author_sort | S. G. Burd |
| collection | DOAJ |
| description | The paper describes a trial dealing with the effect of the formulation of an antiepileptic drug on therapy efficiency, safety, and compliance in epileptic patients. Switching from sustained-release valproates to Depakine®Chronosphere™ demonstrates how the values of efficiency, safety, and compliance vary with the taken dosage form, which ultimately affects quality-of-life indicators and may give rise to their improvement. |
| first_indexed | 2024-04-10T02:03:46Z |
| format | Article |
| id | doaj.art-109f20d61ea24a4191ea17fb22ad6f2b |
| institution | Directory Open Access Journal |
| issn | 2074-2711 2310-1342 |
| language | Russian |
| last_indexed | 2024-04-10T02:03:46Z |
| publishDate | 2013-12-01 |
| publisher | IMA-PRESS LLC |
| record_format | Article |
| series | Неврология, нейропсихиатрия, психосоматика |
| spelling | doaj.art-109f20d61ea24a4191ea17fb22ad6f2b2023-03-13T08:42:13ZrusIMA-PRESS LLCНеврология, нейропсихиатрия, психосоматика2074-27112310-13422013-12-0151S121910.14412/2074-2711-2013-2482214Effect of drug formulation on the treatment of epilepsyS. G. Burd0Department of Neurology, Neurosurgery, and Medical Genetics, N.I. Pirogov Russian National Research Medical University Ministry of Health of Russia, MoscowThe paper describes a trial dealing with the effect of the formulation of an antiepileptic drug on therapy efficiency, safety, and compliance in epileptic patients. Switching from sustained-release valproates to Depakine®Chronosphere™ demonstrates how the values of efficiency, safety, and compliance vary with the taken dosage form, which ultimately affects quality-of-life indicators and may give rise to their improvement.https://nnp.ima-press.net/nnp/article/view/214epilepsyformulationvalproatesdepakine®chronosphere™ |
| spellingShingle | S. G. Burd Effect of drug formulation on the treatment of epilepsy Неврология, нейропсихиатрия, психосоматика epilepsy formulation valproates depakine®chronosphere™ |
| title | Effect of drug formulation on the treatment of epilepsy |
| title_full | Effect of drug formulation on the treatment of epilepsy |
| title_fullStr | Effect of drug formulation on the treatment of epilepsy |
| title_full_unstemmed | Effect of drug formulation on the treatment of epilepsy |
| title_short | Effect of drug formulation on the treatment of epilepsy |
| title_sort | effect of drug formulation on the treatment of epilepsy |
| topic | epilepsy formulation valproates depakine®chronosphere™ |
| url | https://nnp.ima-press.net/nnp/article/view/214 |
| work_keys_str_mv | AT sgburd effectofdrugformulationonthetreatmentofepilepsy |